Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SWX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.
Discovering and developing innovative therapeutics for CNS disorders
Research & Drug Development
Drug Discovery
Newron’s drug discovery programmes are focused on the ion channel target class. The main objectives of these programmes are to provide leads and product candidates to fuel the Company’s pipeline. Lead molecules have been selected showing activity in several CNS disease models, and in particular epilepsy and pain.